Neurokine Pharmaceuticals Inc.
OTC Bulletin Board : NEUKF

Neurokine Pharmaceuticals Inc.

April 27, 2011 14:42 ET

Neurokine Pharmaceuticals Hires Marketing Firm

VANCOUVER, BRITISH COLUMBIA--(Marketwire - April 27, 2011) - Neurokine Pharmaceuticals Inc., (OTCBB:NEUKF) announces the hiring of marketing firm MetaArts Limited.

"We're pleased to be entering into a relationship with MetaArts," said Ahmad Doroudian, president, CEO, and director of Neurokine. "We made the decision to hire a marketing firm because we want to keep investors informed of our latest developments. We're making significant progress in development and trials, so we anticipate having lot of news."

"In the world of small-cap stocks, information is key. Investors need to know what a company doing, how it's performing, and what moves it's making," explained Deborah Rogus, president and owner of MetaArts. "Neuorkine is doing some amazing and important work. We're excited to be a part of it."

About Neurokine

Neurokine Pharmaceuticals Inc., focuses on development of new uses for existing marketed products for diseases mediated by acute and chronic inflammatory reactions. The company is developing proprietary encapsulation technology to allow better blood brain barrier penetration to initiate or enhance therapeutic effects of anti-inflammatory drugs in the treatment of neurodegenerative diseases, such as Alzheimer's.

Safe Harbor Statement:

Except for historical information contained herein, the matters set forth above may be forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ from those in the forward-looking statements. Words such as "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to Neurokine or its management, identify forward-looking statements. Such forward-looking statements are based on the current beliefs of management, as well as assumptions made by and information currently available to management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors such as the level of business and consumer spending, the amount of sales of Neurokine's products, the competitive environment within the industry, the ability of Neurokine to continue to expand its operations, the level of costs incurred in connection with Neurokine's expansion efforts, economic conditions in the industry and the financial strength of Neurokine's customers and suppliers. Neurokine does not undertake any obligation to update such forward-looking statements. Investors are also directed to consider all other risks and uncertainties.

Contact Information